{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:08:47Z","timestamp":1790802527631,"version":"4.1.0"},"reference-count":184,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jaci.2011.11.025","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T11:35:07Z","timestamp":1324726507000},"page":"308-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"title":["International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency"],"prefix":"10.1016","volume":"129","author":[{"given":"Teresa","family":"Caballero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Bouillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gompel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Fagerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Bj\u00f6kander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Bork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Bygum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"de Carolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy H.C.","family":"Gooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Longhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Mart\u00ednez-Saguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Waage","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystina","family":"Obtulowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl\u00a03","key":"10.1016\/j.jaci.2011.11.025_bib1","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib2","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM199606203342510","article-title":"Hereditary angioedema","volume":"334","author":"Cicardi","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1081-1206(10)61121-0","article-title":"Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain","volume":"94","author":"Roche","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2009.09366.x","article-title":"Hereditary angio-oedema in Denmark: a nationwide survey","volume":"161","author":"Bygum","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2011.11.025_bib5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.148.3672.957","article-title":"Hereditary angioneurotic edema: two genetic variants","volume":"148","author":"Rosen","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.11.025_bib6","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.11.025_bib7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","article-title":"Local bradykinin generation in hereditary angioedema","volume":"104","author":"Nussberger","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1567-5769(02)00162-5","article-title":"Bradykinin and the pathophysiology of angioedema","volume":"3","author":"Cugno","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaci.2011.11.025_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2004.05.007","article-title":"The pathophysiology of hereditary angioedema","volume":"114","author":"Davis","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00005792-199207000-00003","article-title":"Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients","volume":"71","author":"Agostoni","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2011.11.025_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJM198305053081810","article-title":"The challenge of hereditary angioneurotic edema","volume":"308","author":"Donaldson","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-84-5-580","article-title":"Hereditary angioedema: the clinical syndrome and its management","volume":"84","author":"Frank","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archinte.163.10.1229","article-title":"Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency","volume":"163","author":"Bork","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.transci.2003.08.007","article-title":"Sudden upper airway obstruction in patients with hereditary angioedema","volume":"29","author":"Bork","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jaci.2011.11.025_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4065\/75.4.349","article-title":"Asphyxiation by laryngeal edema in patients with hereditary angioedema","volume":"75","author":"Bork","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2011.11.025_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0714.1991.tb00908.x","article-title":"Oral manifestations and dental management of patients with hereditary angioedema","volume":"20","author":"Atkinson","year":"1991","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib17","first-page":"1096","article-title":"Potentially fatal hereditary angioedema: s review and case report","volume":"56","author":"Hardie","year":"1990","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.jaci.2011.11.025_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01526-7","article-title":"Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy","volume":"114","author":"Bork","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1440-0960.1992.tb00050.x","article-title":"Hormonally exacerbated hereditary angioedema","volume":"33","author":"Yip","year":"1992","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaci.2011.11.025_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/pgmj.74.867.41","article-title":"Coexistence of hereditary angioedema and Turner\u2019s syndrome","volume":"74","author":"Fletcher","year":"1998","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaci.2011.11.025_bib21","first-page":"54","article-title":"Life-threatening laryngeal oedema in a pregnant woman with hereditary angioedema","volume":"69","author":"McGlinchey","year":"2000","journal-title":"Ulster Med J"},{"key":"10.1016\/j.jaci.2011.11.025_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2796.1996.418764000.x","article-title":"Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses","volume":"239","author":"Nielsen","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.transci.2003.08.009","article-title":"Management of hereditary angioedema: a Canadian approach","volume":"29","author":"Bowen","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2011.11.025_bib24","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S1081-1206(10)60584-4","article-title":"Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema","volume":"100","author":"Bowen","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2005.02726.x","article-title":"C1 inhibitor deficiency: consensus document","volume":"139","author":"Gompels","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-6-24","article-title":"2010 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema","volume":"6","author":"Bowen","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1479-828X.2008.00945.x","article-title":"Hereditary angioedema and pregnancy","volume":"49","author":"Chinniah","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"131","key":"10.1016\/j.jaci.2011.11.025_bib28","first-page":"e1","article-title":"Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate","volume":"203","author":"Martinez-Saguer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaci.2011.11.025_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejogrb.2010.05.008","article-title":"The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey","volume":"152","author":"Czaller","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jaci.2011.11.025_bib30","series-title":"Guide to clinical preventive services: report of the U.S. Preventive Task Force","year":"1989"},{"key":"10.1016\/j.jaci.2011.11.025_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJM198003063021002","article-title":"Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor","volume":"302","author":"Gadek","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2009.07.017","article-title":"Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks","volume":"124","author":"Craig","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0805538","article-title":"Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema","volume":"363","author":"Zuraw","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2007.02.012","article-title":"Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (icatibant)","volume":"119","author":"Bork","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib35","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1398-9995.2006.01197.x","article-title":"Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant","volume":"61","author":"Bas","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2011.11.025_bib36","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1517\/14656566.9.13.2383","article-title":"Therapeutic potential of icatibant (HOE-140, JE-049)","volume":"9","author":"Cruden","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaci.2011.11.025_bib37","first-page":"272","article-title":"Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant","volume":"8","author":"Krause","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaci.2011.11.025_bib38","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaci.2007.04.028","article-title":"Critical role of kallikrein in hereditary angioedema pathogenesis: A\u00a0clinical trial of ecallantide, a novel kallikrein inhibitor","volume":"120","author":"Schneider","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/eci.09.60","article-title":"Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability","volume":"6","author":"Bernstein","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa0905079","article-title":"Ecallantide for the treatment of acute attacks in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib42","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1537-2995.2007.01239.x","article-title":"Recombinant human C1-inhibitor in the treatment of acute angioedema attacks","volume":"47","author":"Choi","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2011.11.025_bib43","first-page":"310","article-title":"Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia","volume":"9","author":"Longhurst","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2011.11.025_bib44","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2010.07.021","article-title":"Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema","volume":"126","author":"Zuraw","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0091-6749(87)80277-4","article-title":"Hereditary angioedema: a decade of management with stanozolol","volume":"80","author":"Sheffer","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00003495-198019050-00007","article-title":"Danazole in the treatment of hereditary angioedema","volume":"19","author":"Hosea","year":"1980","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2011.11.025_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7326\/0003-4819-93-6-809","article-title":"Long-term therapy of hereditary angioedema with danazol","volume":"93","author":"Hosea","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0091-6749(83)90034-9","article-title":"Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives","volume":"72","author":"Cicardi","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib49","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0149-2918(01)80114-4","article-title":"A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids","volume":"23","author":"Shahidi","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaci.2011.11.025_bib50","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0015-0282(16)46331-4","article-title":"Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up","volume":"37","author":"Barbieri","year":"1982","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib51","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(99)00110-5","article-title":"Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema","volume":"353","author":"Bork","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.11.025_bib52","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(02)00035-1","article-title":"Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema","volume":"36","author":"Bork","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaci.2011.11.025_bib53","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(98)80140-2","article-title":"Danazol therapy: An unusual aetiology of hepatocellular carcinoma","volume":"29","author":"Crampon","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaci.2011.11.025_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0015-0282(16)53638-3","article-title":"The long-term safety of danazol in women with hereditary angioedema","volume":"54","author":"Zurlo","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00003081-198812000-00009","article-title":"Danazol-induced pseudomenopause in the management of endometriosis","volume":"31","author":"Dmowski","year":"1988","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jaci.2011.11.025_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000414890","article-title":"Danazol-induced pseudomenopause in the management of endometriosis","volume":"16","author":"Dmowski","year":"1987","journal-title":"Contrib Gynecol Obstet"},{"key":"10.1016\/j.jaci.2011.11.025_bib57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.anplas.2007.05.011","volume":"53","author":"Heusse","year":"2008","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.jaci.2011.11.025_bib58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2007.06.037","article-title":"Hereditary angioedema: safety of long-term stanozolol therapy","volume":"120","author":"Sloane","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2011.11.025_bib59","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1081-1206(10)60582-0","article-title":"Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib60","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities","volume":"295","author":"Gelfand","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib61","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0091-6749(91)90120-D","article-title":"Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience","volume":"87","author":"Cicardi","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib62","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00228-009-0771-z","article-title":"The effect of long-term danazol prophylaxis on liver function in hereditary angioedema\u2014a longitudinal study","volume":"66","author":"Farkas","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.11.025_bib63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3949\/ccjm.57.3.285","article-title":"Use of spironolactone in treatment of hirsutism","volume":"57","author":"Cumming","year":"1990","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib64","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.1982.03320340049034","article-title":"Treatment of hirsutism with spironolactone","volume":"247","author":"Cumming","year":"1982","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jaci.2011.11.025_bib65","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaci.2011.11.025_bib66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0091-6749(97)70095-2","article-title":"Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: Comparison of treated and untreated patients","volume":"99","author":"Cicardi","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib67","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0091-6749(81)90181-0","article-title":"Clinical and biochemical effects of stanozolol therapy for hereditary angioedema","volume":"68","author":"Sheffer","year":"1981","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib68","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM197208312870907","article-title":"Tranexamic acid therapy in hereditary angioneurotic edema","volume":"287","author":"Sheffer","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib69","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1542\/peds.2006-3303","article-title":"Management of hereditary angioedema in pediatric patients","volume":"120","author":"Farkas","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2011.11.025_bib70","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid: a review of its use in surgery and other indications","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2011.11.025_bib71","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0002-9343(90)90535-L","article-title":"Hereditary angioedema: its diagnostic and management perspectives","volume":"88","author":"Sim","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib72","first-page":"1","article-title":"Tranexamic acid therapy is effective treatment in heavy menstrual bleeding: clinical update on safety","volume":"4","author":"Rybo","year":"1991","journal-title":"Ther Adv"},{"key":"10.1016\/j.jaci.2011.11.025_bib73","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/TCRM.S3172","article-title":"Treatment of hereditary angioedema with plasma-derived C1 inhibitor","volume":"4","author":"Prematta","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jaci.2011.11.025_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2003.08.006","article-title":"Safety and efficacy of pasteurized C1 inhibitor concentrate (berinert P) in hereditary angioedema: a review","volume":"29","author":"De Serres","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jaci.2011.11.025_bib75","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1537-2995.2005.00602.x","article-title":"Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema","volume":"45","author":"Bork","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2011.11.025_bib76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biologicals.2006.08.005","article-title":"Viral safety of C1-inhibitor NF","volume":"35","author":"Terpstra","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.jaci.2011.11.025_bib77","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60886-1","article-title":"Fresh frozen plasma for the treatment of hereditary angioedema","volume":"98","author":"Prematta","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2011.11.025_bib78","article-title":"8. hereditary angioedema","volume":"121","author":"Frank","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib79","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1742-1241.2005.00352.x","article-title":"Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?","volume":"59","author":"Longhurst","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaci.2011.11.025_bib80","unstructured":"European Medicines Agency. CHMP public assessment report for Firazyr. EMEA\/350457\/2008. Available at: http:\/\/www.ema.europa.eu\/. Accessed May 31, 2011."},{"key":"10.1016\/j.jaci.2011.11.025_bib81","series-title":"Firazyr (icatibant acetate) [package insert]","year":"2009"},{"key":"10.1016\/j.jaci.2011.11.025_bib82","series-title":"Kalbitor (ecallantide) [package insert]","year":"2009"},{"key":"10.1016\/j.jaci.2011.11.025_bib83","unstructured":"European Medicines Agency. Ruconest. EPAR summary for the public. EMA\/431717\/2010. 2010. Available at: http:\/\/www.ema.europa.eu\/. Accessed May 31, 2011."},{"key":"10.1016\/j.jaci.2011.11.025_bib84","first-page":"157","article-title":"Episodic swelling in a pregnant woman from Bangladesh: evaluation and management of angioedema in pregnancy","volume":"23","author":"Hsieh","year":"2002","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2011.11.025_bib85","first-page":"312","article-title":"Hereditary angioneurotic edema in the puerperium. A\u00a0case report","volume":"36","author":"Cunningham","year":"1991","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib86","unstructured":"Obtulowicz K, Porebski G, Bilo B, Stobiecki M, Obtulowick A. Hereditary angioedema in pregnancy\u2014case series study. The 6th C1-INH Deficiency Workshop; May 22-24, 2009; Budapest, Hungary. Abstract book: 58."},{"key":"10.1016\/j.jaci.2011.11.025_bib87","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1471-0528.1982.tb03615.x","article-title":"Blood levels of proteinase inhibitors in pregnancy","volume":"89","author":"Walker","year":"1982","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaci.2011.11.025_bib88","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0049-3848(81)90206-1","article-title":"C1 inactivator level in pregnancy","volume":"23","author":"Ogston","year":"1981","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2011.11.025_bib89","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0091-6749(05)80025-9","article-title":"C1 esterase inhibitor in pregnancy","volume":"90","author":"Cohen","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib90","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(97)02449-5","article-title":"Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling","volume":"350","author":"Sundberg","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.11.025_bib91","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1093\/humrep\/dep272","article-title":"Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples","volume":"24","author":"Verpoest","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jaci.2011.11.025_bib92","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.rbmo.2010.05.016","article-title":"Case report: first successful application of preimplantation genetic diagnosis for hereditary angiooedema","volume":"21","author":"Bautista-Ll\u00e1cer","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jaci.2011.11.025_bib93","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/humu.9202","article-title":"Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema","volume":"22","author":"Kalmar","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2011.11.025_bib94","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1016\/j.molimm.2008.05.007","article-title":"Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates","volume":"45","author":"Pappalardo","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib95","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1203\/00006450-199402000-00012","article-title":"C1 inhibitor and diagnosis of hereditary angioedema in newborns","volume":"35","author":"Nielsen","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2011.11.025_bib96","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1203\/00006450-197909000-00019","article-title":"Serum complement levels in infancy: age related changes","volume":"13","author":"Davis","year":"1979","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2011.11.025_bib97","first-page":"918","article-title":"Influence of age and sex on serum complement components in children","volume":"135","author":"Roach","year":"1981","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2011.11.025_bib98","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/ejhg.2009.26","article-title":"Genetic testing in asymptomatic minors: recommendations of the European society of human genetics","volume":"17","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jaci.2011.11.025_bib99","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4065\/81.7.958","article-title":"Genetic test indications and interpretations in patients with hereditary angioedema","volume":"81","author":"Weiler","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2011.11.025_bib100","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1542\/peds.37.6.1017","article-title":"Hereditary angioneurotic edema: a clinical survey","volume":"37","author":"Donaldson","year":"1966","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2011.11.025_bib101","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/014107688407701213","article-title":"Hereditary angio-oedema: treatment with C1 esterase inhibitor concentrate","volume":"77","author":"Logan","year":"1984","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib102","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2796.1997.76893000.x","article-title":"Type I hereditary angio-oedema. variability of clinical presentation and course within two large kindreds","volume":"241","author":"Winnewisser","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib103","first-page":"133","article-title":"Hereditary angioedema and pregnancy","volume":"64","author":"Stiller","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaci.2011.11.025_bib104","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-0528.1988.tb06585.x","article-title":"Hereditary angioneurotic oedema and pregnancy. Case reports and review of the literature","volume":"95","author":"Chappatte","year":"1988","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaci.2011.11.025_bib105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","article-title":"Hereditary angioedema: new findings concerning symptoms, affected organs, and course","volume":"119","author":"Bork","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib106","first-page":"112","article-title":"Immunoblotting of plasma in a pregnant patient with hereditary angioedema","volume":"115","author":"Chhibber","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib107","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1471-0528.1994.tb13594.x","article-title":"Danazol prophylaxis for delivery in hereditary angioneurotic oedema","volume":"101","author":"Boulos","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"issue":"484","key":"10.1016\/j.jaci.2011.11.025_bib108","first-page":"e1","article-title":"Disease expression in women with hereditary angioedema","volume":"199","author":"Bouillet","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaci.2011.11.025_bib109","unstructured":"Gooi JHC, Shillito J. Pregnancy and childbirth in women with C1 inh deficiency. The 6th C1-INH Deficiency Workshop; May 22-24, 2009; Budapest, Hungary. Abstract Book: 41."},{"key":"10.1016\/j.jaci.2011.11.025_bib110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2044.1995.tb06050.x","article-title":"Hereditary angioneurotic oedema: current management in pregnancy","volume":"50","author":"Cox","year":"1995","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaci.2011.11.025_bib111","first-page":"519","article-title":"C-1 esterase inhibitor deficiency as an obstetric problem: a case report","volume":"114","author":"Ebert","year":"1992","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.jaci.2011.11.025_bib112","first-page":"507","article-title":"Contraception and pregnancy in hereditary angioedema","volume":"112","author":"Bockers","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jaci.2011.11.025_bib113","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1520\/JFS10855J","article-title":"Hereditary angioneurotic edema: an unusual case of maternal mortality","volume":"24","author":"Postnikoff","year":"1979","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.jaci.2011.11.025_bib114","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1210\/endo.140.7.6871","article-title":"Localization of bradykinin B2 receptors in the endometrium and myometrium of rat uterus and the effects of estrogen and progesterone","volume":"140","author":"Murone","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaci.2011.11.025_bib115","first-page":"365","article-title":"Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate","volume":"54","author":"Gorman","year":"2008","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jaci.2011.11.025_bib116","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaci.2007.06.026","article-title":"Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy","volume":"120","author":"Farkas","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib117","unstructured":"Baker J, Riedl M, Banerji A, Hurewitz D, Levy R, Craig T, et\u00a0al. Treatment or prophylaxis of acute attacks of hereditary angioedema (HAE) in pregnant subjects. WAO International Scientific Conference; December 5-8, 2010; Dubai, United Arab Emirates. Poster 2312."},{"key":"10.1016\/j.jaci.2011.11.025_bib118","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00016347009157244","article-title":"Human placental transfer of an antifibrinolytic agent (AMCA)","volume":"49","author":"Kullander","year":"1970","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jaci.2011.11.025_bib119","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/978-3-642-68511-8_39","article-title":"Effects of tranexamic acid on the coagulation and fibrinolytic systems in pregnancy complicated by placental bleeding","volume":"5","author":"Walzman","year":"1982","journal-title":"Arch Toxicol Suppl"},{"key":"10.1016\/j.jaci.2011.11.025_bib120","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00016340903144238","article-title":"The obstetric experience of women with factor XI deficiency","volume":"88","author":"Chi","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jaci.2011.11.025_bib121","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/en.2003-0478","article-title":"Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep","volume":"145","author":"Manikkam","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaci.2011.11.025_bib122","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0015-0282(16)45329-X","article-title":"Danazol may cause female pseudohermaphroditism","volume":"35","author":"Duck","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib123","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0140-6736(85)92919-8","article-title":"Female pseudohermaphroditism due to maternal androgen administration: 25-year follow-up","volume":"1","author":"Reschini","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.11.025_bib124","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/biolreprod\/81.s1.250","article-title":"Elevated androgens levels during pregnancy impair fetal growth due to placental insufficiency and programs for adult hypertension in rats","volume":"81","author":"Sathishkumar","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1016\/j.jaci.2011.11.025_bib125","first-page":"541","article-title":"Fresh frozen plasma prophylaxis for hereditary angioedema during pregnancy. A\u00a0case report","volume":"41","author":"Galan","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib126","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2500\/aap.2009.30.3225","article-title":"Modern preoperative and intraoperative management of hereditary angioedema","volume":"30","author":"Szema","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2011.11.025_bib127","first-page":"287","article-title":"Termination of pregnancy in a patient with hereditary angioedema","volume":"58","author":"Raychaudhuri","year":"1997","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib128","first-page":"209","article-title":"Hereditary angioneurotic oedema in three families. symptomatic heterogeneity, complement analysis and therapeutic trials","volume":"191","author":"Blohme","year":"1972","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jaci.2011.11.025_bib129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2044.1979.tb06276.x","article-title":"Hereditary angioneurotic oedema","volume":"34","author":"Hopkinson","year":"1979","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaci.2011.11.025_bib130","first-page":"65","article-title":"Hereditary angioneurotic edema and pregnancy","volume":"19","author":"Hardy","year":"1990","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jaci.2011.11.025_bib131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1710-1492-6-22","article-title":"HAE international home therapy consensus document","volume":"6","author":"Longhurst","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib132","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1081-1206(10)60424-3","article-title":"Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients","volume":"100","author":"Bork","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib133","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00554669","article-title":"Pharmacokinetics and bioavailability of tranexamic acid","volume":"20","author":"Pilbrant","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2011.11.025_bib134","first-page":"54","article-title":"Tranexamic acid (Lysteda) for treatment of menorrhagia","volume":"52","year":"2010","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.jaci.2011.11.025_bib135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2165\/00003495-198019050-00001","article-title":"Pharmacology and pharmacokinetics of danazol","volume":"19","author":"Potts","year":"1980","journal-title":"Drugs"},{"key":"10.1016\/j.jaci.2011.11.025_bib136","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/13543784.15.9.1077","article-title":"The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema","volume":"15","author":"Levy","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2011.11.025_bib137","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2265.2004.02009.x","article-title":"Sex hormones in hereditary angioneurotic oedema","volume":"60","author":"Visy","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaci.2011.11.025_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00016348409156383","article-title":"Drug use during pregnancy and breast-feeding. A\u00a0classification system for drug information","volume":"126","author":"Berglund","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.jaci.2011.11.025_bib139","series-title":"Compendium of pharmaceutical and specialties","first-page":"311","year":"1993"},{"key":"10.1016\/j.jaci.2011.11.025_bib140","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000247874","article-title":"Hereditary angioedema and oral contraception","volume":"181","author":"Borradori","year":"1990","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaci.2011.11.025_bib141","first-page":"762","article-title":"Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives","volume":"96","author":"Gordon","year":"1980","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib142","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0039-128X(96)00037-2","article-title":"Estrogen induction and contact phase activation of human factor XII","volume":"61","author":"Citarella","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.jaci.2011.11.025_bib143","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood.V66.3.602.602","article-title":"The influence of estrogen and prolactin on Hageman factor (factor XII) titer in ovariectomized and hypophysectomized rats","volume":"66","author":"Gordon","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.11.025_bib144","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0167-4781(92)90069-C","article-title":"Differential regulation of kininogen gene expression by estrogen and progesterone in\u00a0vivo","volume":"1131","author":"Chen","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2011.11.025_bib145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0049-3848(91)90343-U","article-title":"Contact activation factors in plasma from women using oral contraceptives\u2014increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein","volume":"64","author":"Hoem","year":"1991","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaci.2011.11.025_bib146","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/1047-2797(92)90093-6","article-title":"Estrogen-associated thromboembolism","volume":"2","author":"Wessler","year":"1992","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jaci.2011.11.025_bib147","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-0528.1993.tb12956.x","article-title":"Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill","volume":"100","author":"Campbell","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaci.2011.11.025_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2008.01.032","article-title":"Contraception in hereditary angioedema","volume":"90","author":"Sanhueza","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib149","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2133.2004.06152.x","article-title":"Hereditary angio-oedema: effective treatment with the progestogen-only pill in a young woman","volume":"151","author":"Amar","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2011.11.025_bib150","first-page":"2023","article-title":"Norgestrienone, a possible therapeutic agent in hereditary angioneurotic edema","volume":"15","author":"Wautier","year":"1986","journal-title":"Presse Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib151","first-page":"2132","article-title":"Hereditary angioneurotic edema: norgestrienone is not effective in every case","volume":"16","author":"Laurent","year":"1987","journal-title":"Presse Med"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2011.11.025_bib152","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.maturitas.2003.09.016","article-title":"Differential effects of progestins on hemostasis","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.jaci.2011.11.025_bib153","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2265.2006.02704.x","article-title":"Treatment of hereditary angioneurotic oedema (HANE) with tibolone","volume":"66","author":"Ott","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaci.2011.11.025_bib154","first-page":"2431","article-title":"Contraceptions in women with contra-indication to estrogen-progestins","volume":"45","author":"Gompel","year":"1995","journal-title":"Rev Prat"},{"key":"10.1016\/j.jaci.2011.11.025_bib155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jaci.2011.11.025_bib156","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2010.08.012","article-title":"Pregnane progestin contraception in systemic lupus erythematosus: a longitudinal study of 187 patients","volume":"83","author":"Chabbert-Buffet","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.jaci.2011.11.025_bib157","first-page":"45","article-title":"Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study)","volume":"15","author":"Pelissier","year":"1987","journal-title":"Contracept Fertil Sex (Paris)"},{"key":"10.1016\/j.jaci.2011.11.025_bib158","first-page":"37","article-title":"Antiovulatory action of chlormadinone acetate","volume":"22","author":"Pelissier","year":"1994","journal-title":"Contracept Fertil Sex (Paris)"},{"key":"10.1016\/j.jaci.2011.11.025_bib159","first-page":"301","article-title":"Recurrent angioedema associated with hypogonadism or anti-androgen therapy","volume":"63","author":"Pichler","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2011.11.025_bib160","unstructured":"Cimbollek S, Gonz\u00e1lez-Quevedo T, D\u00edaz M. To become or not become pregnant with hereditary angioedema. The 5th C1-INH Deficiency Workshop; May 31-June 2, 2007; Budapest, Hungary. Abstract book: 30."},{"key":"10.1016\/j.jaci.2011.11.025_bib161","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00000441-200009000-00014","article-title":"Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman","volume":"320","author":"McGlinchey","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaci.2011.11.025_bib162","first-page":"52","article-title":"Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII","volume":"111","author":"Gordon","year":"1988","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2011.11.025_bib163","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1046\/j.1538-7836.2003.00362.x","article-title":"Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women","volume":"1","author":"Madsen","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2011.11.025_bib164","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/01.ATV.20.5.1404","article-title":"Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis","volume":"20","author":"Teede","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaci.2011.11.025_bib165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00042192-200105000-00011","article-title":"Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women","volume":"8","author":"Nogawa","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.jaci.2011.11.025_bib166","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.HYP.33.1.323","article-title":"Estrogen regulation of angiotensin-converting enzyme mRNA","volume":"33","author":"Gallagher","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jaci.2011.11.025_bib167","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.2005.04.7324","article-title":"Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group trial N99C7","volume":"24","author":"Loprinzi","year":"2006","journal-title":"J Clin Oncol"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2011.11.025_bib168","first-page":"S19","article-title":"Progesterone for vasomotor symptoms: a 12-week randomized, masked placebo-controlled trial in healthy, normal-weight women 1-10 years since final menstrual flow [abstract]","volume":"31","author":"Hitchcock","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaci.2011.11.025_bib169","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(08)60346-3","article-title":"Menopause","volume":"371","author":"Nelson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.11.025_bib170","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/annonc\/mdp295","article-title":"Tamoxifen contraindicated in women with hereditary angioedema?","volume":"20","author":"Rousset-Jablonski","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaci.2011.11.025_bib171","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.1992.tb05858.x","article-title":"Cystic ovaries in women affected with hereditary angioedema","volume":"90","author":"Perricone","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2011.11.025_bib172","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-3083.2000.00652.x","article-title":"Impaired human ovarian follicular fluid complement function in hereditary angioedema","volume":"51","author":"Perricone","year":"2000","journal-title":"Scand J Immunol"},{"issue":"suppl\u00a04","key":"10.1016\/j.jaci.2011.11.025_bib173","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.fertnstert.2006.11.153","article-title":"Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue","volume":"88","author":"Fechner","year":"2007","journal-title":"Fertil Steril"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2011.11.025_bib174","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(02)04813-6","article-title":"Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas","volume":"79","author":"Ishihara","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib175","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.fertnstert.2005.12.074","article-title":"Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism","volume":"86","author":"Murakami","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib176","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/gyno.2000.5731","article-title":"Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix","volume":"77","author":"Lacey","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaci.2011.11.025_bib177","first-page":"354","article-title":"Response of serum hormones to androgen administration in power athletes","volume":"17","author":"Alen","year":"1985","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jaci.2011.11.025_bib178","first-page":"624","article-title":"Suppression of spermatogenesis by testosterone enanthate in Thai men","volume":"79","author":"Aribarg","year":"1996","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jaci.2011.11.025_bib179","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/jcem-70-1-282","article-title":"Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production","volume":"70","author":"Matsumoto","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaci.2011.11.025_bib180","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/humupd\/dmp003","article-title":"Intrauterine insemination","volume":"15","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jaci.2011.11.025_bib181","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.fertnstert.2009.06.033","article-title":"Ovarian stimulation for ovulation induction and in\u00a0vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"92","author":"Bellver","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib182","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2010.03.028","article-title":"Preventing ovarian hyperstimulation syndrome: guidance for the clinician","volume":"94","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2011.11.025_bib183","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1472-6483(10)60042-9","article-title":"Symposium: update on prediction and management of OHSS. A\u00a0modern classification of OHSS","volume":"19","author":"Golan","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jaci.2011.11.025_bib184","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/GCO.0b013e328329c2b8","article-title":"The \u2018ART\u2019 of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology","volume":"21","author":"Chan","year":"2009","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911018306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911018306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:33:49Z","timestamp":1758789229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911018306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0091674911018306"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.11.025","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14267219.15779415","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}